Gilead Sciences, Inc.
|Number of Estimates|
Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. Its primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.
Market Cap: 81.8 Billion
Primary Exchange: NASDAQ
Shares Outstanding: 1.27 Billion
Float: 1.26 Billion
Dividend: 2.46 (0.04%)
Sector: Health Technology
Short Interest (Jan 12, 2018): 21.8 Million
Longest drawdown: 1278 trading days
From: 2015-06-23 To: 2019-11-12
Akero Therapeutics Readies $75 Million IPO
via: SeekingAlpha at 2019-06-13 09:11:26:000
Quick Take Akero Therapeutics ( AKRO ) has filed to raise gross proceeds of $75.0 million from a U.S. IPO, according to an S-1/A registration statement . The firm is developing a treatment for metabolic diseases with high unmet clinical needs, with an initial focus on non-alcoholic steato… read more...
June 2019 Stock Considerations
via: SeekingAlpha at 2019-06-12 23:24:27:000
After a wild May we seem to be trending back up in June. Of course, anyone in the DGI space already knows that these daily, weekly and monthly swings really don't matter to anyone with a very long-term time horizon. All we can do in the meantime is watch the market swing, stay in the game, fin… read more...
BIIB Is For Buy-O-Gen
via: SeekingAlpha at 2019-06-12 06:30:36:000
Let's spell Biogen Buy-o-Gen. Indeed, BIIB seems increasingly appealing at current price. The biotech focuses on discovering, developing, and delivering therapies to people living with serious neurological, rare and autoimmune diseases. The Company markets various products for multiple sc… read more...
Gilead Hopes To Continue Sales Expansion Of Yescarta - Results From KTE-X19 Step In The Right Direction
via: SeekingAlpha at 2019-06-11 13:29:35:000
Gilead Sciences ( GILD ) reported final results from its phase 1 study using its CAR-T cell therapy KTE-X19 to treat patients with relapsed/refractory acute lymphoblastic leukemia ((ALL)). This was early clinical data that was presented at the American Society for Clinical Oncology ((ASCO)) … read more...
How To Find Undervalued Stocks In The Healthcare Sector
via: SeekingAlpha at 2019-06-10 12:10:41:000
The healthcare sector is underperforming the market by a wide margin on a year to date basis. The Healthcare Select Sector ETF ( XLV ) has gained 5.2%, while the SPDR S&P 500 ( SPY ) is up by almost three times that, with a cumulative gain of 15.1% in the same period. Data by YCharts … read more...
Dividend Challenger Highlights: Week Of June 9
via: SeekingAlpha at 2019-06-10 02:40:50:000
Introduction The Dividend Champions list is a monthly compilation of companies which have consistently increased their annual dividend payouts, and the latest edition may be found here . However, since this list is only produced once per month, the data in it can quickly get out of date. Fu… read more...
|Ex-Date||Payment Date||Record Date||Declared Date||Amount||Flag||Dividend Type||Qualified||Indicated|
|2019-09-12||2019-09-27||2019-09-13||2019-07-30||0.63||No Change QoQ|
|2019-06-13||2019-06-27||2019-06-14||2019-05-02||0.63||No Change QoQ|
|2018-12-13||2018-12-28||2018-12-14||2018-10-25||0.57||No Change QoQ|
|2018-09-13||2018-09-27||2018-09-14||2018-07-25||0.57||No Change QoQ|
|2018-06-14||2018-06-28||2018-06-15||2018-05-01||0.57||No Change QoQ|
|2017-12-14||2017-12-28||2017-12-15||2017-10-26||0.52||No Change QoQ|
|2017-09-14||2017-09-28||2017-09-15||2017-07-26||0.52||No Change QoQ|
|2017-06-14||2017-06-29||2017-06-16||2017-05-02||0.52||No Change QoQ|
|2016-12-13||2016-12-29||2016-12-15||2016-11-01||0.47||No Change QoQ|
|2016-09-14||2016-09-29||2016-09-16||2016-07-25||0.47||No Change QoQ|
|2016-03-14||2016-03-30||2016-03-16||2016-02-02||0.43||No Change QoQ|
|2015-12-14||2015-12-30||2015-12-16||2015-10-27||0.43||No Change QoQ|
|2015-09-14||2015-09-29||2015-09-16||2015-07-28||0.43||No Change QoQ|
|2015-06-12||2015-06-29||2015-06-16||2015-04-30||0.43||No Change QoQ|
|Ex-Date||Declared Date||Record Date||Payment Date||Ratio||To Factor||For Factor|
|2013-01-28||2012-12-10||2013-01-07||2013-01-25 00:00:00 -0500||0.5||2.0||1.0|